This inventor holds 1 USPTO granted patent. Top assignees: Mcgill University, Sanford Burnham Prebys Medical Discovery Institute, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 570 
1 out of 99 
1 out of 3,693 
Years Active: 2020
Title: Ivan Topisirovic: Innovator in Translation Initiation Complex Inhibition
Introduction
Ivan Topisirovic is a notable inventor based in California, recognized for his contributions to the field of pharmaceutical sciences. He has developed innovative compounds that play a significant role in modulating the eukaryotic translation initiation factor 4F (eIF4F) complex. His work has implications for various therapeutic applications.
Latest Patents
Ivan Topisirovic holds a patent for "Quinolinones as inhibitors of translation initiation complex." This patent includes compounds and pharmaceutical compositions comprising quinolinones, which are useful as modulators of the eIF4F complex. He has 1 patent to his name, showcasing his innovative approach to addressing complex biological mechanisms.
Career Highlights
Throughout his career, Ivan has worked with esteemed institutions, including the Sanford Burnham Prebys Medical Discovery Institute and McGill University. His experience in these organizations has allowed him to collaborate with leading scientists and contribute to groundbreaking research in his field.
Collaborations
Ivan has collaborated with various professionals, including his coworker Anthony B. Pinkerton. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Ivan Topisirovic is a distinguished inventor whose work in translation initiation complex inhibition has the potential to advance therapeutic strategies. His innovative contributions continue to influence the field of pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile